Session date: 
08/11/2017 - 12:15pm to 1:00pm

Gonda 8-104/Joseph 1-242

Nathan Staff, M.D., Ph.D.
"Amyotropic Lateral Sclerosis: Treatment and Trial Updates"

Learning objectives:
identify the clinical features of ALS and its therapeutic challenges
summarize key attributes of FDA-approved medications for ALS
appraise experimental therapies for ALS

The presenter (and/or spouse/partner) has the following relevant financial relationship to disclose: co-investigaor for clinical trials - Brainstorm Therapeutics
The presenter does not intend to discuss an off-label/investigative use of a commercial product/device.

Where did the idea for the course originate?: 
Minnesota
Please login or register to take this course.
Where did the idea for the course originate?: 
Minnesota